Results 121 to 130 of about 54,597 (215)

<i>Brucella</i>'s Emerging Threat: A Global Systematic Review and Meta-Analysis Revealing Temporal, Geographic and Species-Specific Patterns of Antimicrobial Resistance. [PDF]

Vet Med Int
Tut G.
europepmc   +1 more source

Shifting Antimicrobial Susceptibility Patterns of Uropathogens: A 20‐Year Analysis of Urine Cultures

International Journal of Urology, Volume 33, Issue 3, March 2026.
ABSTRACT Objectives Antimicrobial resistance among uropathogens, particularly extended‐spectrum β‐lactamase (ESBL) production and fluoroquinolone (FQ) resistance, presents a significant challenge to treating urinary tract infections (UTIs). This study aimed to analyze 20‐year trends in antimicrobial susceptibility among key urinary isolates at a single
Shinichi Takebe, Masami Endo, Nanaho Demizu, Mei Tokumoto, Ryota Morinaga, Taku Mitome, Akitoshi Takizawa   +6 more
wiley   +1 more source

The Brief Case: Adjudication of discrepant genotypic and phenotypic antimicrobial susceptibility testing results in a patient with <i>Staphylococcus aureus</i> bacteremia. [PDF]

J Clin Microbiol
Reyes Curcio F, McCallum J, Borrelli G, Orr B, Weiss Z, Nussbaum EZ.   +5 more
europepmc   +1 more source

In Reply to Flawed Critique of CLSI Guideline EP05-A2

The Journal of Applied Laboratory Medicine, 2022
Robert Frenkel, Ian Farrance
openaire   +2 more sources

Antimicrobial Resistance and Infant Mortality in Sri Lanka: A Retrospective Cohort Study

Journal of Paediatrics and Child Health, Volume 62, Issue 3, Page 446-455, March 2026.
ABSTRACT Objective Sepsis is a major cause of mortality among children, with the highest burden evident in neonates and young infants, particularly, in resource‐constrained healthcare settings. Despite this burden, there are insufficient published data to delineate the epidemiology of neonatal sepsis from many of these settings.
Gayana P. S. Gunaratna, Michelle L. Harrison, Benjamin F. R. Dickson, Rajeev Sathanandaraja, T. M. Ruwanthi Perera, Nambage Shirani Chandrasiri, Anasuya Sutharson, Jannah Baker, Phoebe C. M. Williams   +8 more
wiley   +1 more source

The Need for a Revision of Fluoroquinolone Breakpoints for Interpretation of Antimicrobial Susceptibility Testing of Feline Bacterial Isolates

Journal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 2, Page 131-140, March 2026.
ABSTRACT The fluoroquinolone antimicrobial agents, enrofloxacin and marbofloxacin, were approved in the United States for cats in 1990 and 2001, respectively. In 2023, revised breakpoints for testing isolates from dogs were published. These canine breakpoints are discordant with the current feline breakpoints.
Mark G. Papich, Lacie A. Gunnett, Marilyn N. Martinez   +2 more
wiley   +1 more source

Performance of gradient diffusion strip and disk diffusion versus broth microdilution for lefamulin susceptibility testing of 422 <i>Staphylococcus aureus</i> isolates. [PDF]

J Clin Microbiol
Tian Y, He X, Wu X, Liu Y, Wang X, Jin Y, Wang G, Zhang Z.   +7 more
europepmc   +1 more source

Time Kill Curve PD Modelling Experiments Are Affected by Trailing MIC Endpoints: Refinement of MIC Determination for S. pseudintermedius

Journal of Veterinary Pharmacology and Therapeutics, Volume 49, Issue 2, Page 220-227, March 2026.
ABSTRACT Trailing endpoints are a recognised challenge in broth microdilution MIC testing, particularly for bacteriostatic agents such as trimethoprim (TMP) and sulphonamides. In this study, we applied a pharmacodynamically guided refinement to determine the MIC of the combination against Staphylococcus pseudintermedius; we did not aim at redefining ...
Andrew Mead, Ludovic Pelligand
wiley   +1 more source

Optimizing facility-specific urinary weighted-incidence syndromic antibiograms for nursing homes. [PDF]

Infect Control Hosp Epidemiol
Taylor LN, Gangnon R, Howe M, Perez F, Jolles S, Furuno J, Nace D, Jump R, Crnich C.   +8 more
europepmc   +1 more source

Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species

Mycoses, Volume 69, Issue 3, March 2026.
ABSTRACT Background Although Aspergillus fumigatus remains the primary cause of invasive aspergillosis, other species—including emerging cryptic ones—are increasingly identified in clinical settings. These species often exhibit distinct antifungal susceptibility profiles, emphasising the importance of species‐level identification for effective patient ...
Manuela Loaiza‐Oliva, Paula Funes, María Mercedes Romero, María Sol Barbagelata, Soledad Gamarra, Guillermo Garcia‐Effron   +5 more
wiley   +1 more source